T2 Biosystems, Inc.
(NASDAQ : TTOO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. 1.46%243.821.3%$795.90m
IMMUImmunomedics, Inc. 0.07%85.3611.0%$697.18m
MRNAModerna, Inc. 6.60%69.470.0%$666.49m
NVAXNovavax, Inc. 10.86%113.5696.5%$629.01m
ILMNIllumina, Inc. 4.74%299.893.5%$582.79m
GILDGilead Sciences, Inc. 0.00%62.251.0%$574.11m
REGNRegeneron Pharmaceuticals, Inc. 2.98%574.062.7%$443.39m
VRTXVertex Pharmaceuticals, Inc. 1.92%268.181.9%$340.86m
BIIBBiogen, Inc. 1.20%273.281.6%$334.97m
ALXNAlexion Pharmaceuticals, Inc. 2.15%114.432.0%$285.22m
EXASEXACT Sciences Corp. 3.60%97.7020.7%$257.29m
SRNESorrento Therapeutics, Inc. 4.84%9.641.5%$240.99m
VXRTVaxart, Inc. 7.40%7.400.0%$213.88m
SGENSeattle Genetics, Inc. 3.08%184.956.0%$212.14m
MNTAMomenta Pharmaceuticals, Inc. 0.02%52.403.0%$193.58m

Company Profile

T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.